Medicare Enrolled
Dr. Maya Rankova, M.D.
Internal Medicine · Far Rockaway, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rankova from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rankova?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rankova
Dr. Maya Rankova is an internal medicine specialist in Far Rockaway, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rankova performed 9,040 Medicare services across 2,131 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rankova received a total of $7,662 from 43 pharmaceutical and/or device companies across 454 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rankova is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in NY
$7,662 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,040
Medicare services
Top 2% in NY for internal medicine
2,131
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~476 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,097 | $54 | $100 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
796 | $61 | $104 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
787 | $1 | $15 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
780 | $19 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
748 | $83 | $130 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
736 | $1 | $20 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
733 | $35 | $55 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
730 | $1 | $12 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
483 | $40 | $100 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
314 | $52 | $100 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
217 | $72 | $150 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
212 | $291 | $372 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
212 | $7 | $15 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
212 | $185 | $250 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
128 | $0 | $8 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
106 | $30 | $50 |
| Assessment of muscle signal of pelvic nerves This procedure evaluates the electrical activity or signal of muscles innervated by the pelvic nerves. It is used to assess the functional status of these nerves and the muscles they control. |
106 | $95 | $122 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
104 | $81 | $120 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
103 | $25 | $100 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
101 | $116 | $250 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
74 | $148 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
38 | $13 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
36 | $118 | $200 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 27 | $250 | $350 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
22 | $73 | $150 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
21 | $35 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $105 | $200 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
20 | $184 | $244 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 16 | $20 | $50 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
16 | $13 | $35 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $36 | $50 |
| Annual depression screening | 15 | $22 | $50 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $83 | $137 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.1% high complexity
26.2% medium
47.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,662
Total received (2018-2024)
Avg $1,095/year across 7 years
Top 11% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
454
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,662 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$853
2023
$1,086
2022
$1,217
2021
$1,187
2020
$904
2019
$1,110
2018
$1,305
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$214
Eisai Inc.
$150
Novo Nordisk Inc
$93
Amgen Inc.
$92
Lilly USA, LLC
$75
PFIZER INC.
$67
Merck Sharp & Dohme LLC
$45
Lundbeck LLC
$41
Azurity Pharmaceuticals, Inc.
$31
Renalytix AI, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$21
Top 3 companies account for 53.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$891
ABBVIE INC.
$860
AstraZeneca Pharmaceuticals LP
$715
AbbVie Inc.
$569
Novo Nordisk Inc
$396
PFIZER INC.
$358
Allergan Inc.
$351
Amgen Inc.
$286
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$277
Biohaven Pharmaceutical Holding Company Ltd.
$267
Merck Sharp & Dohme LLC
$250
SANOFI-AVENTIS U.S. LLC
$239
Amarin Pharma Inc.
$237
Janssen Pharmaceuticals, Inc
$230
Lilly USA, LLC
$172
Merck Sharp & Dohme Corporation
$169
Eisai Inc.
$169
AbbVie, Inc.
$125
SK Life Science, Inc.
$125
Novartis Pharmaceuticals Corporation
$124
E.R. Squibb & Sons, L.L.C.
$111
Gilead Sciences, Inc.
$82
ARALEZ PHARMACEUTICALS US INC.
$79
Astellas Pharma US Inc
$55
Allergan, Inc.
$55
Global Blood Therapeutics, Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$44
Lundbeck LLC
$41
Renalytix AI, Inc.
$39
Circassia Pharmaceuticals Inc
$39
Azurity Pharmaceuticals, Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Exact Sciences Corporation
$28
Collegium Pharmaceutical, Inc.
$21
Bausch Health US, LLC
$20
Nestle HealthCare Nutrition Inc.
$19
ARBOR PHARMACEUTICALS, INC.
$18
Pernix Therapeutics Holdings, Inc.
$18
Esperion Therapeutics, Inc.
$18
Kowa Pharmaceuticals America, Inc.
$17
Avadel Specialty Pharmaceuticals, LLC
$17
Avanir Pharmaceuticals, Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$13
Top 3 companies account for 32.2% of all-time payments
Associated products mentioned in payments ›
ADVAIR · ANORO · ANORO ELLIPTA · APLENZIN · Aimovig · BELSOMRA · BREO · BRILINTA · BYSTOLIC · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · Creon · Dayvigo · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · FARXIGA · INVOKANA · JANUVIA · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KISUNLA · Kerendia · LANTUS · LINZESS · Leqembi · Livalo · MOUNJARO · MYRBETRIQ · NAMZARIC · NEXLETOL · NUCALA · NUEDEXTA · NURTEC ODT · Noctiva · OXBRYTA · Otezla · Ozempic · PAXLOVID · Prolia · QULIPTA · QUVIVIQ · REXULTI · Ranexa · Repatha · Rybelsus · SHINGRIX · SILENOR · SOLIQUA 100/33 · SYMBICORT · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tresiba · UBRELVY · VERQUVO · VIBERZI · VRAYLAR · Vascepa · XARELTO · XCOPRI · XIFAXAN · XTAMPZA · ZENPEP · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
9,688
Per 100K population
415.8
County median income
$84,961
Nearest hospital
ST JOHN'S EPISCOPAL HOSPITAL AT SOUTH SHORE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rankova is a clinical cardiology specialist, with above-average Medicare volume (top 2% in NY), with low-engagement industry engagement in the top 11% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rankova experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Rankova performed 1,097 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rankova receive payments from pharmaceutical companies?
Yes. Dr. Rankova received a total of $7,662 from 43 companies across 454 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rankova's costs compare to other internal medicine physicians in Far Rockaway?
Dr. Rankova's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rankova) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Far Rockaway
Browse internal medicine physicians in Far Rockaway ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology